| Year |
Citation |
Score |
| 2024 |
Guo Y, Endmayr V, Zekeridou A, McKeon A, Leypoldt F, Hess K, Kalinowska-Lyszczarz A, Klang A, Pakozdy A, Höftberger E, Hametner S, Haider C, De Simoni D, Peters S, Gelpi E, ... ... Lucchinetti CF, et al. New insights into neuropathology and pathogenesis of autoimmune glial fibrillary acidic protein meningoencephalomyelitis. Acta Neuropathologica. 147: 31. PMID 38310187 DOI: 10.1007/s00401-023-02678-7 |
0.319 |
|
| 2024 |
Gupta P, Paul P, Redenbaugh V, Guo Y, Lucchinetti C, Abdulrahman Y, Datta A, Shah S, Klein CJ, Pittock SJ, Flanagan EP, Dubey D. Peripheral nervous system manifestations of MOG antibody associated disease. Annals of Clinical and Translational Neurology. PMID 38234084 DOI: 10.1002/acn3.52001 |
0.3 |
|
| 2023 |
Yandamuri SS, Filipek B, Obaid AH, Lele N, Thurman JM, Makhani N, Nowak RJ, Guo Y, Lucchinetti CF, Flanagan EP, Longbrake EE, O'Connor KC. MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity. Jci Insight. PMID 37097758 DOI: 10.1172/jci.insight.165373 |
0.309 |
|
| 2023 |
Jackson-Tarlton C, Londoño D, Lucchinetti CF, Duffy DJ, Weigand SD, Tillema JM, Kalinowska-Lyszczarz A, Tobin WO. ADC restriction is not associated with clinical response to plasma exchange following a cerebral attack of multiple sclerosis. Multiple Sclerosis and Related Disorders. 73: 104676. PMID 37019056 DOI: 10.1016/j.msard.2023.104676 |
0.332 |
|
| 2023 |
Kalinowska-Lyszczarz A, Tillema JM, Tobin WO, Guo Y, Weigand SD, Metz I, Brück W, Lassmann H, Giraldo-Chica M, Port JD, Lucchinetti CF. Long-term clinical, imaging and cognitive outcomes association with MS immunopathology. Annals of Clinical and Translational Neurology. PMID 36759436 DOI: 10.1002/acn3.51723 |
0.332 |
|
| 2023 |
Cacciaguerra L, Morris P, Tobin WO, Chen JJ, Banks SA, Elsbernd P, Redenbaugh V, Tillema JM, Montini F, Sechi E, Lopez-Chiriboga AS, Zalewski N, Guo Y, Rocca MA, Filippi M, ... ... Lucchinetti CF, et al. Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder. Neurology. PMID 36690455 DOI: 10.1212/WNL.0000000000206820 |
0.458 |
|
| 2022 |
B Syc-Mazurek S, Chen JJ, Morris P, Sechi E, Mandrekar J, Tillema JM, Lopez-Chiriboga AS, Lucchinetti CF, Zalewski N, Cacciaguerra L, Buciuc M, Krecke KN, Messina SA, Bhatti MT, Pittock SJ, et al. Frequency of New or Enlarging Lesions on MRI Outside of Clinical Attacks in Patients With MOG-Antibody-Associated Disease. Neurology. PMID 36175150 DOI: 10.1212/WNL.0000000000201263 |
0.402 |
|
| 2022 |
Kalinowska-Łyszczarz A, Guo Y, Lucchinetti CF. Update on pathology of central nervous system inflammatory demyelinating diseases. Neurologia I Neurochirurgia Polska. 56: 201-209. PMID 35758517 DOI: 10.5603/PJNNS.a2022.0046 |
0.476 |
|
| 2022 |
Hardy TA, Guo Y, Flanagan EP, Lucchinetti CF, Tobin WO. The clinical spectrum of haemorrhagic CNS inflammatory demyelinating lesions. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221094241. PMID 35581949 DOI: 10.1177/13524585221094241 |
0.322 |
|
| 2021 |
Guo Y, Lennon VA, Parisi JE, Popescu B, Vasquez C, Pittock SJ, Howe CL, Lucchinetti CF. Spectrum of sublytic astrocytopathy in neuromyelitis optica. Brain : a Journal of Neurology. PMID 34718426 DOI: 10.1093/brain/awab394 |
0.341 |
|
| 2021 |
Tobin WO, Kalinowska-Lyszczarz A, Weigand SD, Guo Y, Tosakulwong N, Parisi JEE, Metz I, Frischer JM, Lassmann H, Brück W, Linbo L, Lucchinetti CF. Clinical Correlation of Multiple Sclerosis Immunopathologic Subtypes. Neurology. PMID 34504026 DOI: 10.1212/WNL.0000000000012782 |
0.313 |
|
| 2021 |
Sechi E, Krecke KN, Messina SA, Buciuc M, Pittock SJ, Chen JJ, Weinshenker BG, Lopez-Chiriboga AS, Lucchinetti CF, Zalewski NL, Tillema JM, Kunchok A, Monaco S, Morris PP, Fryer JP, et al. Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders. Neurology. PMID 34261784 DOI: 10.1212/WNL.0000000000012467 |
0.42 |
|
| 2021 |
Jolliffe EA, Guo Y, Hardy TA, Morris PP, Flanagan EP, Lucchinetti CF, Tobin WO. Clinical and Radiologic Features, Pathology, and Treatment of Baló Concentric Sclerosis. Neurology. PMID 34011576 DOI: 10.1212/WNL.0000000000012230 |
0.311 |
|
| 2020 |
Banks SA, Morris PP, Chen JJ, Pittock SJ, Sechi E, Kunchok A, Tillema JM, Fryer JP, Weinshenker BG, Krecke KN, Lopez-Chiriboga AS, Nguyen A, Greenwood TM, Lucchinetti CF, Zalewski NL, et al. Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 33372052 DOI: 10.1136/jnnp-2020-325121 |
0.38 |
|
| 2020 |
Tham M, Frischer JM, Weigand SD, Fitz-Gibbon PD, Webb SM, Guo Y, Adiele RC, Robinson CA, Brück W, Lassmann H, Furber KL, Pushie MJ, Parisi JE, Lucchinetti CF, Popescu BF. Iron heterogeneity in early active multiple sclerosis lesions. Annals of Neurology. PMID 33244761 DOI: 10.1002/ana.25974 |
0.329 |
|
| 2020 |
Lopez-Chiriboga S, Sechi E, Buciuc M, Chen JJ, Pittock SJ, Lucchinetti CF, Flanagan EP. Long-term Outcomes in Patients With Myelin Oligodendrocyte Glycoprotein Immunoglobulin G-Associated Disorder. Jama Neurology. PMID 32865549 DOI: 10.1001/Jamaneurol.2020.3115 |
0.34 |
|
| 2020 |
Wilkins JM, Gakh O, Kabiraj P, McCarthy CB, Tobin WO, Howe CL, Lucchinetti CF. Signatures of cell stress and altered bioenergetics in skin fibroblasts from patients with multiple sclerosis. Aging. 12. PMID 32640422 DOI: 10.18632/aging.103612 |
0.308 |
|
| 2020 |
Reichard RR, Kashani KB, Boire NA, Constantopoulos E, Guo Y, Lucchinetti CF. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathologica. PMID 32449057 DOI: 10.1007/S00401-020-02166-2 |
0.402 |
|
| 2020 |
Höftberger R, Guo Y, Flanagan EP, Lopez-Chiriboga AS, Endmayr V, Hochmeister S, Joldic D, Pittock SJ, Tillema JM, Gorman M, Lassmann H, Lucchinetti CF. The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody. Acta Neuropathologica. PMID 32048003 DOI: 10.1007/S00401-020-02132-Y |
0.534 |
|
| 2020 |
Jitprapaikulsan J, Fryer JP, Majed M, Smith CY, Jenkins SM, Cabre P, Hinson SR, Weinshenker BG, Mandrekar J, Chen JJ, Lucchinetti CF, Jiao Y, Segan J, Schmeling JE, Mills J, et al. Clinical utility of AQP4-IgG titers and measures of complement-mediated cell killing in NMOSD Neuroimmunology and Neuroinflammation. 7. DOI: 10.1212/Nxi.0000000000000727 |
0.37 |
|
| 2019 |
Zekeridou A, Kryzer T, Guo Y, Hassan A, Lennon V, Lucchinetti CF, Pittock S, McKeon A. Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity. Neurology. PMID 31315972 DOI: 10.1212/Wnl.0000000000007971 |
0.316 |
|
| 2018 |
Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, Weinshenker BG, Shosha E, Lucchinetti CF, Fryer JP, Lopez-Chiriboga AS, Chen JC, Jitprapaikulsan J, McKeon A, Gadoth A, et al. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody. Jama Neurology. PMID 30575890 DOI: 10.1001/Jamaneurol.2018.4053 |
0.393 |
|
| 2018 |
Waubant E, Amezcua L, Sicotte N, Hellwig K, Krupp L, Weinstock-Guttman B, Yeh A, Lucas RM, Longbrake EE, Yadav V, Rensel M, Mar S, Hersh C, Block V, Zipp F, ... ... Lucchinetti C, et al. Gender Inequities in the Multiple Sclerosis Community: A Call for Action Annals of Neurology. 84: 958-959. PMID 30387521 DOI: 10.1002/Ana.25359 |
0.305 |
|
| 2018 |
Parks NE, Pittock SJ, Mandrekar J, Kantarci OH, Lucchinetti CF, Weinshenker BG, Keegan BM, Tobin WO, Tillema JM, Toledano M, Flanagan EP. Population-based study of "no evident disease activity" in MS. Neurology(R) Neuroimmunology & Neuroinflammation. 5: e495. PMID 30211251 DOI: 10.1212/Nxi.0000000000000495 |
0.393 |
|
| 2018 |
Chen JJ, Flanagan EP, Jitprapaikulsan J, Chiriboga ASSL, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, et al. Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG)-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues and Outcome. American Journal of Ophthalmology. PMID 30055153 DOI: 10.1016/J.Ajo.2018.07.020 |
0.363 |
|
| 2018 |
López-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, Jitprapaikulsan J, Kothapalli N, Tillema JM, Chen J, Weinshenker B, Wingerchuk D, Sagen J, Gadoth A, Lennon VA, ... ... Lucchinetti C, et al. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders. Jama Neurology. PMID 30014148 DOI: 10.1001/Jamaneurol.2018.1814 |
0.426 |
|
| 2018 |
Marin Collazo IV, Howe CL, Lucchinetti CF, Tobin WO. Neuromyelitis Optica and Herpes Simplex Virus 2: A Viral Trigger for Aquaporin-4 Autoimmunity? The Neurologist. 23: 92-93. PMID 29722742 DOI: 10.1097/Nrl.0000000000000172 |
0.337 |
|
| 2018 |
Jitprapaikulsan J, Chen JJ, Flanagan EP, Tobin WO, Fryer JP, Weinshenker BG, McKeon A, Lennon VA, Leavitt JA, Tillema JM, Lucchinetti C, Keegan BM, Kantarci O, Khanna C, Jenkins SM, et al. Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis. Ophthalmology. PMID 29716788 DOI: 10.1016/J.Ophtha.2018.03.041 |
0.332 |
|
| 2018 |
Tillema JM, Weigand SD, Dayan M, Shu Y, Kantarci OH, Lucchinetti CF, Port JD. Dark Rims: Novel Sequence Enhances Diagnostic Specificity in Multiple Sclerosis. Ajnr. American Journal of Neuroradiology. PMID 29700044 DOI: 10.3174/Ajnr.A5636 |
0.447 |
|
| 2018 |
Stork L, Ellenberger D, Beißbarth T, Friede T, Lucchinetti CF, Brück W, Metz I. Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis. Jama Neurology. PMID 29404583 DOI: 10.1001/Jamaneurol.2017.4842 |
0.432 |
|
| 2018 |
Reich DS, Lucchinetti CF, Calabresi PA. Multiple Sclerosis. The New England Journal of Medicine. 378: 169-180. PMID 29320652 DOI: 10.1056/NEJMra1401483 |
0.355 |
|
| 2017 |
Parks NE, Flanagan EP, Lucchinetti CF, Wingerchuk DM. NEDA treatment target? No evident disease activity as an actionable outcome in practice. Journal of the Neurological Sciences. 383: 31-34. PMID 29246616 DOI: 10.1016/J.Jns.2017.10.015 |
0.388 |
|
| 2017 |
Linnoila J, Guo Y, Gadoth A, Raghunathan A, Parks B, McKeon A, Lucchinetti CF, Lennon VA, Pittock SJ. Purkinje cell cytoplasmic antibody type I (anti-Yo): predictive of gastrointestinal adenocarcinomas in men. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29142142 DOI: 10.1136/Jnnp-2017-316829 |
0.33 |
|
| 2017 |
Tobin WO, Guo Y, Krecke KN, Parisi JE, Lucchinetti CF, Pittock SJ, Mandrekar J, Dubey D, Debruyne J, Keegan BM. Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain : a Journal of Neurology. 140: 2415-2425. PMID 29050399 DOI: 10.1093/Brain/Awx200 |
0.407 |
|
| 2017 |
Popescu BF, Frischer JM, Webb SM, Tham M, Adiele RC, Robinson CA, Fitz-Gibbon PD, Weigand SD, Metz I, Nehzati S, George GN, Pickering IJ, Brück W, Hametner S, Lassmann H, ... ... Lucchinetti CF, et al. Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions. Acta Neuropathologica. PMID 28332093 DOI: 10.1007/S00401-017-1696-8 |
0.418 |
|
| 2017 |
Guo Y, Weigand SD, Popescu BF, Lennon VA, Parisi JE, Pittock SJ, Parks NE, Clardy SL, Howe CL, Lucchinetti CF. Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica. Acta Neuropathologica. PMID 28184993 DOI: 10.1007/S00401-017-1682-1 |
0.429 |
|
| 2016 |
Zalewski NL, Morris PP, Weinshenker BG, Lucchinetti CF, Guo Y, Pittock SJ, Krecke KN, Kaufmann TJ, Wingerchuk DM, Kumar N, Flanagan EP. Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27913626 DOI: 10.1136/Jnnp-2016-314738 |
0.327 |
|
| 2016 |
Tobin WO, Costanzi C, Guo Y, Parisi JE, Weigand SD, Lucchinetti CF. Clinical-radiological-pathological spectrum of central nervous system-idiopathic inflammatory demyelinating disease in the elderly. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27760861 DOI: 10.1177/1352458516675748 |
0.44 |
|
| 2016 |
Tillema JM, Weigand SD, Mandrekar J, Shu Y, Lucchinetti CF, Pirko I, Port JD. In vivo detection of connectivity between cortical and white matter lesions in early MS. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27698248 DOI: 10.1177/1352458516671027 |
0.46 |
|
| 2016 |
Wang Y, Cao Y, Mangalam AK, Guo Y, LaFrance-Corey RG, Gamez JD, Atanga PA, Clarkson BD, Zhang Y, Wang E, Angom RS, Dutta K, Ji B, Pirko I, Lucchinetti CF, et al. Neuropilin-1 modulates interferon-γ-stimulated signaling in brain microvascular endothelial cells. Journal of Cell Science. PMID 27591257 DOI: 10.1242/Jcs.190702 |
0.384 |
|
| 2016 |
Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S, Belman AL. Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome. Neurology. 87: S38-45. PMID 27572859 DOI: 10.1212/Wnl.0000000000002825 |
0.476 |
|
| 2016 |
Hardy TA, Reddel SW, Barnett MH, Palace J, Lucchinetti CF, Weinshenker BG. Atypical inflammatory demyelinating syndromes of the CNS. The Lancet. Neurology. 15: 967-81. PMID 27478954 DOI: 10.1016/S1474-4422(16)30043-6 |
0.487 |
|
| 2016 |
Chuang TY, Guo Y, Seki SM, Rosen AM, Johanson DM, Mandell JW, Lucchinetti CF, Gaultier A. LRP1 expression in microglia is protective during CNS autoimmunity. Acta Neuropathologica Communications. 4: 68. PMID 27400748 DOI: 10.1186/S40478-016-0343-2 |
0.499 |
|
| 2016 |
Russi AE, Walker-Caulfield ME, Guo Y, Lucchinetti CF, Brown MA. Meningeal mast cell-T cell crosstalk regulates T cell encephalitogenicity. Journal of Autoimmunity. PMID 27396526 DOI: 10.1016/J.Jaut.2016.06.015 |
0.305 |
|
| 2016 |
Popescu BF, Lucchinetti CF. Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis. Handbook of Clinical Neurology. 133: 95-106. PMID 27112673 DOI: 10.1016/B978-0-444-63432-0.00006-2 |
0.555 |
|
| 2016 |
Goodin DS, Reder AT, Bermel RA, Cutter GR, Fox RJ, John GR, Lublin FD, Lucchinetti CF, Miller AE, Pelletier D, Racke MK, Trapp BD, Vartanian T, Waubant E. Relapses in multiple sclerosis: Relationship to disability. Multiple Sclerosis and Related Disorders. 6: 10-20. PMID 27063617 DOI: 10.1016/J.Msard.2015.09.002 |
0.433 |
|
| 2016 |
Hardy TA, Tobin WO, Lucchinetti CF. Exploring the overlap between multiple sclerosis, tumefactive demyelination and Baló's concentric sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27037180 DOI: 10.1177/1352458516641776 |
0.495 |
|
| 2016 |
Flanagan EP, Cabre P, Weinshenker BG, St Sauver J, Jacobson DJ, Majed M, Lennon VA, Lucchinetti CF, McKeon A, Matiello M, Kale N, Wingerchuk DM, Mandrekar J, Sagen JA, Fryer JP, et al. Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum. Annals of Neurology. PMID 26891082 DOI: 10.1002/Ana.24617 |
0.33 |
|
| 2016 |
Pittock SJ, Lucchinetti CF. Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later. Annals of the New York Academy of Sciences. 1366: 20-39. PMID 26096370 DOI: 10.1111/Nyas.12794 |
0.464 |
|
| 2015 |
Tobin WO, Popescu BF, Lowe V, Pirko I, Parisi JE, Kantarci K, Fields JA, Bruns MB, Boeve BF, Lucchinetti CF. Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26447065 DOI: 10.1177/1352458515604382 |
0.312 |
|
| 2015 |
Walker-Caulfield ME, Guo Y, Johnson RK, McCarthy CB, Fitz-Gibbon PD, Lucchinetti CF, Howe CL. NFκB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG. Journal of Neuroinflammation. 12: 185. PMID 26423139 DOI: 10.1186/S12974-015-0403-8 |
0.43 |
|
| 2015 |
Frischer JM, Weigand SD, Guo Y, Kale N, Parisi JE, Pirko I, Mandrekar J, Bramow S, Metz I, Brück W, Lassmann H, Lucchinetti CF. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Annals of Neurology. 78: 710-21. PMID 26239536 DOI: 10.1002/Ana.24497 |
0.447 |
|
| 2015 |
Novotna M, Paz Soldán MM, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M, et al. Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis. Neurology. 85: 722-9. PMID 26208962 DOI: 10.1212/Wnl.0000000000001856 |
0.461 |
|
| 2015 |
Ransohoff RM, Hafler DA, Lucchinetti CF. Multiple sclerosis-a quiet revolution. Nature Reviews. Neurology. 11: 134-42. PMID 25686758 DOI: 10.1038/Nrneurol.2015.14 |
0.442 |
|
| 2015 |
Pfeifenbring S, Bunyan RF, Metz I, Röver C, Huppke P, Gärtner J, Lucchinetti CF, Brück W. Extensive acute axonal damage in pediatric multiple sclerosis lesions. Annals of Neurology. 77: 655-67. PMID 25612167 DOI: 10.1002/Ana.24364 |
0.45 |
|
| 2015 |
Popescu BF, Guo Y, Jentoft ME, Parisi JE, Lennon VA, Pittock SJ, Weinshenker BG, Wingerchuk DM, Giannini C, Metz I, Brück W, Shuster EA, Carter J, Boyd CD, Clardy SL, ... ... Lucchinetti CF, et al. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions. Neurology. 84: 148-58. PMID 25503621 DOI: 10.1212/Wnl.0000000000001126 |
0.431 |
|
| 2015 |
Paz Soldán MM, Novotna M, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Weinshenker BG, Rodriguez M, Kantarci OH. Relapses and disability accumulation in progressive multiple sclerosis. Neurology. 84: 81-8. PMID 25398229 DOI: 10.1212/Wnl.0000000000001094 |
0.452 |
|
| 2015 |
Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A, Wingerchuk DM, Shuster EA, Jiao Y, Horta ES, Pittock SJ. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. Jama Neurology. 72: 81-7. PMID 25384099 DOI: 10.1001/Jamaneurol.2014.2137 |
0.457 |
|
| 2014 |
Brickshawana A, Hinson SR, Romero MF, Lucchinetti CF, Guo Y, Buttmann M, McKeon A, Pittock SJ, Chang MH, Chen AP, Kryzer TJ, Fryer JP, Jenkins SM, Cabre P, Lennon VA. Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study. The Lancet. Neurology. 13: 795-806. PMID 25008548 DOI: 10.1016/S1474-4422(14)70141-3 |
0.49 |
|
| 2014 |
Guo Y, Lennon VA, Popescu BF, Grouse CK, Topel J, Milone M, Lassmann H, Parisi JE, Pittock SJ, Stefoski D, Balabanov R, Lucchinetti CF. Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum. Jama Neurology. 71: 1025-9. PMID 24911400 DOI: 10.1001/Jamaneurol.2014.775 |
0.361 |
|
| 2014 |
Robinson CA, Adiele RC, Tham M, Lucchinetti CF, Popescu BF. Early and widespread injury of astrocytes in the absence of demyelination in acute haemorrhagic leukoencephalitis. Acta Neuropathologica Communications. 2: 52. PMID 24887055 DOI: 10.1186/2051-5960-2-52 |
0.437 |
|
| 2014 |
Tobin WO, Weinshenker BG, Lucchinetti CF. Longitudinally extensive transverse myelitis. Current Opinion in Neurology. 27: 279-89. PMID 24792338 DOI: 10.1097/Wco.0000000000000093 |
0.358 |
|
| 2014 |
Metz I, Weigand SD, Popescu BF, Frischer JM, Parisi JE, Guo Y, Lassmann H, Brück W, Lucchinetti CF. Pathologic heterogeneity persists in early active multiple sclerosis lesions. Annals of Neurology. 75: 728-38. PMID 24771535 DOI: 10.1002/Ana.24163 |
0.481 |
|
| 2014 |
Clardy SL, Lucchinetti CF, Krecke KN, Lennon VA, O'Toole O, Weinshenker BG, Boyd CD, Krieger S, McGraw C, Guo Y, Pittock SJ. Hydrocephalus in neuromyelitis optica. Neurology. 82: 1841-3. PMID 24759842 DOI: 10.1212/Wnl.0000000000000428 |
0.358 |
|
| 2014 |
Figueroa M, Guo Y, Tselis A, Pittock SJ, Lennon VA, Lucchinetti CF, Lisak RP. Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4. Jama Neurology. 71: 495-8. PMID 24733266 DOI: 10.1001/Jamaneurol.2013.6331 |
0.33 |
|
| 2014 |
Howe CL, Kaptzan T, Magaña SM, Ayers-Ringler JR, Lafrance-Corey RG, Lucchinetti CF. Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures Glia. 62: 692-708. PMID 24492996 DOI: 10.1002/Glia.22635 |
0.773 |
|
| 2014 |
Lucchinetti CF, Guo Y, Popescu BF, Fujihara K, Itoyama Y, Misu T. The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathology (Zurich, Switzerland). 24: 83-97. PMID 24345222 DOI: 10.1111/Bpa.12099 |
0.533 |
|
| 2014 |
Jiao Y, Fryer JP, Lennon VA, McKeon A, Jenkins SM, Smith CY, Quek AM, Weinshenker BG, Wingerchuk DM, Shuster EA, Lucchinetti CF, Pittock SJ. Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis. Jama Neurology. 71: 48-54. PMID 24248262 DOI: 10.1001/Jamaneurol.2013.5055 |
0.371 |
|
| 2014 |
Tobin WO, Popescu B, Lowe VJ, Pirko I, Kantarci K, Fields JA, Boeve BF, Lucchinetti CF. Multiple Sclerosis Masquerading As Alzheimer'S Type Dementia: Clinical, Radiological, And Pathological Findings Alzheimers & Dementia. 10: 630. DOI: 10.1016/J.Jalz.2014.05.1097 |
0.343 |
|
| 2013 |
Popescu BF, Bunyan RF, Guo Y, Parisi JE, Lennon VA, Lucchinetti CF. Evidence of aquaporin involvement in human central pontine myelinolysis. Acta Neuropathologica Communications. 1: 40. PMID 24252214 DOI: 10.1186/2051-5960-1-40 |
0.433 |
|
| 2013 |
Wüthrich C, Popescu BF, Gheuens S, Marvi M, Ziman R, Denq SP, Tham M, Norton E, Parisi JE, Dang X, Lucchinetti CF, Koralnik IJ. Natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis: a postmortem study. Journal of Neuropathology and Experimental Neurology. 72: 1043-51. PMID 24128680 DOI: 10.1097/Nen.0000000000000005 |
0.525 |
|
| 2013 |
Jiao Y, Fryer JP, Lennon VA, Jenkins SM, Quek AM, Smith CY, McKeon A, Costanzi C, Iorio R, Weinshenker BG, Wingerchuk DM, Shuster EA, Lucchinetti CF, Pittock SJ. Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology. 81: 1197-204. PMID 23997151 DOI: 10.1212/Wnl.0B013E3182A6Cb5C |
0.326 |
|
| 2013 |
Popescu BF, Pirko I, Lucchinetti CF. Pathology of multiple sclerosis: where do we stand? Continuum (Minneapolis, Minn.). 19: 901-21. PMID 23917093 DOI: 10.1212/01.CON.0000433291.23091.65 |
0.369 |
|
| 2013 |
Pittock SJ, Lennon VA, McKeon A, Mandrekar J, Weinshenker BG, Lucchinetti CF, O'Toole O, Wingerchuk DM. Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. The Lancet. Neurology. 12: 554-62. PMID 23623397 DOI: 10.1016/S1474-4422(13)70076-0 |
0.378 |
|
| 2013 |
Iorio R, Lucchinetti CF, Lennon VA, Farrugia G, Pasricha PJ, Weinshenker BG, Pittock SJ. Intractable nausea and vomiting from autoantibodies against a brain water channel. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 11: 240-5. PMID 23211959 DOI: 10.1016/J.Cgh.2012.11.021 |
0.397 |
|
| 2013 |
Tutuncu M, Tang J, Zeid NA, Kale N, Crusan DJ, Atkinson EJ, Siva A, Pittock SJ, Pirko I, Keegan BM, Lucchinetti CF, Noseworthy JH, Rodriguez M, Weinshenker BG, Kantarci OH. Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 188-98. PMID 22736750 DOI: 10.1177/1352458512451510 |
0.451 |
|
| 2012 |
Costanzi C, Bourdette D, Parisi JE, Woltjer R, Rodriguez F, Steensma D, Lucchinetti CF. Crystal-storing histiocytosis: An unusual relapsing inflammatory CNS disorder. Multiple Sclerosis and Related Disorders. 1: 95-9. PMID 25876937 DOI: 10.1016/J.Msard.2011.12.003 |
0.451 |
|
| 2012 |
Cook SD, Dhib-Jalbut S, Dowling P, Durelli L, Ford C, Giovannoni G, Halper J, Harris C, Herbert J, Li D, Lincoln JA, Lisak R, Lublin FD, Lucchinetti CF, Moore W, et al. Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010. International Journal of Ms Care. 14: 105-14. PMID 24453741 DOI: 10.7224/1537-2073-14.3.105 |
0.462 |
|
| 2012 |
Brück W, Popescu B, Lucchinetti CF, Markovic-Plese S, Gold R, Thal DR, Metz I. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate. Annals of Neurology. 72: 385-94. PMID 23034911 DOI: 10.1002/Ana.23621 |
0.515 |
|
| 2012 |
Quek AM, McKeon A, Lennon VA, Mandrekar JN, Iorio R, Jiao Y, Costanzi C, Weinshenker BG, Wingerchuk DM, Lucchinetti CF, Shuster EA, Pittock SJ. Effects of age and sex on aquaporin-4 autoimmunity. Archives of Neurology. 69: 1039-43. PMID 22507888 DOI: 10.1001/Archneurol.2012.249 |
0.308 |
|
| 2012 |
Filippi M, Rocca MA, Barkhof F, Brück W, Chen JT, Comi G, DeLuca G, De Stefano N, Erickson BJ, Evangelou N, Fazekas F, Geurts JJ, Lucchinetti C, Miller DH, Pelletier D, et al. Association between pathological and MRI findings in multiple sclerosis. The Lancet. Neurology. 11: 349-60. PMID 22441196 DOI: 10.1016/S1474-4422(12)70003-0 |
0.487 |
|
| 2012 |
Popescu BF, Lucchinetti CF. Meningeal and cortical grey matter pathology in multiple sclerosis. Bmc Neurology. 12: 11. PMID 22397318 DOI: 10.1186/1471-2377-12-11 |
0.499 |
|
| 2012 |
Popescu BF, Lucchinetti CF. Pathology of demyelinating diseases. Annual Review of Pathology. 7: 185-217. PMID 22313379 DOI: 10.1146/Annurev-Pathol-011811-132443 |
0.539 |
|
| 2012 |
Hinson SR, Romero MF, Popescu BF, Lucchinetti CF, Fryer JP, Wolburg H, Fallier-Becker P, Noell S, Lennon VA. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proceedings of the National Academy of Sciences of the United States of America. 109: 1245-50. PMID 22128336 DOI: 10.1073/Pnas.1109980108 |
0.427 |
|
| 2012 |
Lennon VA, Hinson SR, Fallier-Becker P, Romero MF, Lucchinetti CF. Immunohistopathological findings in neuromyelitis optica concur with immunobiological observations in vitro Proceedings of the National Academy of Sciences of the United States of America. 109. DOI: 10.15496/Publikation-6836 |
0.312 |
|
| 2012 |
Costanzi C, Bunyan R, Guo Y, Parisi J, Linbo L, Lucchinetti C. Clinical-Radiological-Pathological Spectrum of CNS Inflammatory Demyelinating Disease in the Elderly (P03.048) Neurology. 78: P03.048-P03.048. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P03.048 |
0.398 |
|
| 2012 |
Rahmlow M, Sorenson E, Crum B, Lucchinetti C, Kantarci O, Carter J. The Co-Occurrence of MS and ALS: Chance or Shared Biology? (P02.147) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P02.147 |
0.338 |
|
| 2012 |
Lennon VA, Hinson SR, Romero MF, Fallier-Becker P, Lucchinetti CF. Reply to Rossi et al.: Immunohistopathological findings in neuromyelitis optica concur with immunobiological observations in vitro Proceedings of the National Academy of Sciences of the United States of America. 109: 201204361. DOI: 10.1073/Pnas.1204361109 |
0.427 |
|
| 2011 |
Lucchinetti CF, Popescu BF, Bunyan RF, Moll NM, Roemer SF, Lassmann H, Brück W, Parisi JE, Scheithauer BW, Giannini C, Weigand SD, Mandrekar J, Ransohoff RM. Inflammatory cortical demyelination in early multiple sclerosis. The New England Journal of Medicine. 365: 2188-97. PMID 22150037 DOI: 10.1056/Nejmoa1100648 |
0.454 |
|
| 2011 |
Iorio R, Lucchinetti C, Lennon V, Costanzi C, Hinson S, Weinshenker B, Pittock S. Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica Neurology. 77: 1644-1646. PMID 21998320 DOI: 10.1212/Wnl.0B013E3182343377 |
0.484 |
|
| 2011 |
Popescu BF, Bunyan RF, Parisi JE, Ransohoff RM, Lucchinetti CF. A case of multiple sclerosis presenting with inflammatory cortical demyelination. Neurology. 76: 1705-10. PMID 21576686 DOI: 10.1212/Wnl.0B013E31821A44F1 |
0.468 |
|
| 2011 |
Bunyan RF, Popescu BF, Carter JL, Caselli RJ, Parisi JE, Lucchinetti CF. Childhood-onset multiple sclerosis with progressive dementia and pathological cortical demyelination. Archives of Neurology. 68: 525-8. PMID 21482934 DOI: 10.1001/Archneurol.2011.50 |
0.449 |
|
| 2011 |
Almekhlafi MA, Clark AW, Lucchinetti CF, Zhang Y, Power C, Bell RB. Neuromyelitis optica with extensive active brain involvement: an autopsy study. Archives of Neurology. 68: 508-12. PMID 21482930 DOI: 10.1001/Archneurol.2011.62 |
0.32 |
|
| 2011 |
Magaña SM, Keegan BM, Weinshenker BG, Erickson BJ, Pittock SJ, Lennon VA, Rodriguez M, Thomsen K, Weigand S, Mandrekar J, Linbo L, Lucchinetti CF. Beneficial plasma exchange response in central nervous system inflammatory demyelination. Archives of Neurology. 68: 870-8. PMID 21403003 DOI: 10.1001/Archneurol.2011.34 |
0.422 |
|
| 2011 |
Jones DT, Mateen FJ, Lucchinetti CF, Jack CR, Welker KM. Default mode network disruption secondary to a lesion in the anterior thalamus. Archives of Neurology. 68: 242-7. PMID 20937938 DOI: 10.1001/Archneurol.2010.259 |
0.346 |
|
| 2010 |
Apiwattanakul M, Popescu BF, Matiello M, Weinshenker BG, Lucchinetti CF, Lennon VA, McKeon A, Carpenter AF, Miller GM, Pittock SJ. Intractable vomiting as the initial presentation of neuromyelitis optica. Annals of Neurology. 68: 757-61. PMID 21031587 DOI: 10.1002/Ana.22121 |
0.348 |
|
| 2010 |
Bramow S, Frischer JM, Lassmann H, Koch-Henriksen N, Lucchinetti CF, Sørensen PS, Laursen H. Demyelination versus remyelination in progressive multiple sclerosis. Brain : a Journal of Neurology. 133: 2983-98. PMID 20855416 DOI: 10.1093/brain/awq250 |
0.397 |
|
| 2010 |
Pittock SJ, Parisi JE, McKeon A, Roemer SF, Lucchinetti CF, Tan KM, Keegan BM, Hunter SF, Duncan PR, Baehring JM, Matsumoto JY, Lennon VA. Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri). Archives of Neurology. 67: 1109-15. PMID 20837856 DOI: 10.1001/Archneurol.2010.209 |
0.386 |
|
| 2010 |
Young NP, Weinshenker BG, Parisi JE, Scheithauer B, Giannini C, Roemer SF, Thomsen KM, Mandrekar JN, Erickson BJ, Lucchinetti CF. Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain : a Journal of Neurology. 133: 333-48. PMID 20129932 DOI: 10.1093/Brain/Awp321 |
0.469 |
|
| 2009 |
Kale N, Pittock SJ, Lennon VA, Thomsen K, Roemer S, McKeon A, Lucchinetti CF. Humoral pattern II multiple sclerosis pathology not associated with neuromyelitis Optica IgG. Archives of Neurology. 66: 1298-9. PMID 19822791 DOI: 10.1001/Archneurol.2009.199 |
0.517 |
|
| 2009 |
Hu W, Lucchinetti CF. The pathological spectrum of CNS inflammatory demyelinating diseases. Seminars in Immunopathology. 31: 439-53. PMID 19779719 DOI: 10.1007/S00281-009-0178-Z |
0.54 |
|
| 2009 |
Staff NP, Lucchinetti CF, Keegan BM. Multiple sclerosis with predominant, severe cognitive impairment. Archives of Neurology. 66: 1139-43. PMID 19752304 DOI: 10.1001/Archneurol.2009.190 |
0.367 |
|
| 2009 |
McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Hinson SR, Kryzer TJ, Lucchinetti CF, Weinshenker BG, Wingerchuk DM, Shuster EA, Pittock SJ. Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Archives of Neurology. 66: 1134-8. PMID 19752303 DOI: 10.1001/Archneurol.2009.178 |
0.34 |
|
| 2009 |
Jacob A, Matiello M, Weinshenker BG, Wingerchuk DM, Lucchinetti C, Shuster E, Carter J, Keegan BM, Kantarci OH, Pittock SJ. Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Jama Neurology. 66: 1128-1133. PMID 19752302 DOI: 10.1001/Archneurol.2009.175 |
0.397 |
|
| 2009 |
Magaña SM, Pittock SJ, Lennon VA, Keegan BM, Weinshenker BG, Lucchinetti CF. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease. Archives of Neurology. 66: 964-6. PMID 19667216 DOI: 10.1001/Archneurol.2009.152 |
0.797 |
|
| 2009 |
Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Lassmann H. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain : a Journal of Neurology. 132: 1175-89. PMID 19339255 DOI: 10.1093/Brain/Awp070 |
0.505 |
|
| 2009 |
Magaña SM, Matiello M, Pittock SJ, McKeon A, Lennon VA, Rabinstein AA, Shuster E, Kantarci OH, Lucchinetti CF, Weinshenker BG. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology. 72: 712-7. PMID 19237699 DOI: 10.1212/01.Wnl.0000343001.36493.Ae |
0.73 |
|
| 2009 |
Daniels TB, Pollock BE, Miller RC, Lucchinetti CF, Leavitt JA, Brown PD. Radiation-induced optic neuritis after pituitary adenoma radiosurgery in a patient with multiple sclerosis: case report. Journal of Neuro-Oncology. 93: 263-7. PMID 19099198 DOI: 10.1007/S11060-008-9766-3 |
0.323 |
|
| 2009 |
McKeon A, Lennon VA, Jacob A, Matiello M, Lucchinetti CF, Kale N, Chan KH, Weinshenker BG, Apiwattinakul M, Wingerchuk DM, Pittock SJ. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle & Nerve. 39: 87-90. PMID 19086079 DOI: 10.1002/Mus.21197 |
0.411 |
|
| 2008 |
Quintana FJ, Farez MF, Viglietta V, Iglesias AH, Merbl Y, Izquierdo G, Lucas M, Basso AS, Khoury SJ, Lucchinetti CF, Cohen IR, Weiner HL. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 105: 18889-94. PMID 19028871 DOI: 10.1073/Pnas.0806310105 |
0.391 |
|
| 2008 |
Hinson SR, Roemer SF, Lucchinetti CF, Fryer JP, Kryzer TJ, Chamberlain JL, Howe CL, Pittock SJ, Lennon VA. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. The Journal of Experimental Medicine. 205: 2473-81. PMID 18838545 DOI: 10.1084/Jem.20081241 |
0.423 |
|
| 2008 |
Rodriguez FJ, Gamez JD, Vrana JA, Theis JD, Giannini C, Scheithauer BW, Parisi JE, Lucchinetti CF, Pendlebury WW, Bergen HR, Dogan A. Immunoglobulin derived depositions in the nervous system: novel mass spectrometry application for protein characterization in formalin-fixed tissues. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 1024-37. PMID 18711355 DOI: 10.1038/Labinvest.2008.72 |
0.384 |
|
| 2008 |
Scarisbrick IA, Linbo R, Vandell AG, Keegan M, Blaber SI, Blaber M, Sneve D, Lucchinetti CF, Rodriguez M, Diamandis EP. Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration. Biological Chemistry. 389: 739-45. PMID 18627300 DOI: 10.1515/Bc.2008.085 |
0.469 |
|
| 2008 |
McKeon A, Lennon VA, Lotze T, Tenenbaum S, Ness JM, Rensel M, Kuntz NL, Fryer JP, Homburger H, Hunter J, Weinshenker BG, Krecke K, Lucchinetti CF, Pittock SJ. CNS aquaporin-4 autoimmunity in children. Neurology. 71: 93-100. PMID 18509092 DOI: 10.1212/01.Wnl.0000314832.24682.C6 |
0.436 |
|
| 2008 |
Porter AB, Giannini C, Kaufmann T, Lucchinetti CF, Wu W, Decker PA, Atkinson JL, O'Neill BP. Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use: a pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma. Annals of Neurology. 63: 662-7. PMID 18481293 DOI: 10.1002/Ana.21366 |
0.329 |
|
| 2008 |
Young NP, Weinshenker BG, Lucchinetti CF. Acute disseminated encephalomyelitis: current understanding and controversies. Seminars in Neurology. 28: 84-94. PMID 18256989 DOI: 10.1055/S-2007-1019130 |
0.471 |
|
| 2008 |
Lucchinetti CF. Multiple sclerosis and the spectrum of CNS inflammatory demyelinating diseases. Seminars in Neurology. 28: 3-6. PMID 18256982 DOI: 10.1055/S-2007-1019123 |
0.485 |
|
| 2008 |
Lassmann H, Lucchinetti CF. Cortical demyelination in CNS inflammatory demyelinating diseases. Neurology. 70: 332-3. PMID 18227414 DOI: 10.1212/01.Wnl.0000298724.89870.D1 |
0.492 |
|
| 2008 |
Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zéphir H, Moder K, Weinshenker BG. Neuromyelitis optica and non organ-specific autoimmunity. Archives of Neurology. 65: 78-83. PMID 18195142 DOI: 10.1001/Archneurol.2007.17 |
0.317 |
|
| 2008 |
Banwell B, Tenembaum S, Lennon VA, Ursell E, Kennedy J, Bar-Or A, Weinshenker BG, Lucchinetti CF, Pittock SJ. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders Neurology. 70: 344-352. PMID 18094334 DOI: 10.1212/01.Wnl.0000284600.80782.D5 |
0.439 |
|
| 2008 |
Patrikios PT, Stadelmann C, Kutzelnigg A, Laursen H, Sorensen PS, Brueck W, Lucchinetti C, Lassmann H. 447: Remyelination is extensive in a subset of multiple sclerosis patients Journal of Clinical Neuroscience. 15: 358. DOI: 10.1016/J.Jocn.2007.07.058 |
0.452 |
|
| 2007 |
Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, Lennon VA. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology. 69: 2221-31. PMID 17928579 DOI: 10.1212/01.Wnl.0000289761.64862.Ce |
0.471 |
|
| 2007 |
Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. The Lancet. Neurology. 6: 805-15. PMID 17706564 DOI: 10.1016/S1474-4422(07)70216-8 |
0.513 |
|
| 2007 |
Lassmann H, Brück W, Lucchinetti CF. Erratum: The immunopathology of multiple sclerosis: An overview (Brain Pathology (2007) 17 (210-218)) Brain Pathology. 17. PMID 17598826 DOI: 10.1111/J.1750-3639.2007.00078.X |
0.391 |
|
| 2007 |
Jacob A, Matiello M, Wingerchuk DM, Lucchinetti CF, Pittock SJ, Weinshenker BG. Neuromyelitis optica: changing concepts. Journal of Neuroimmunology. 187: 126-38. PMID 17512987 DOI: 10.1016/J.Jneuroim.2007.04.009 |
0.446 |
|
| 2007 |
Wingerchuk DM, Lucchinetti CF. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis. Current Opinion in Neurology. 20: 343-50. PMID 17495631 DOI: 10.1097/Wco.0B013E3280Be58D8 |
0.461 |
|
| 2007 |
Kutzelnigg A, Faber-Rod JC, Bauer J, Lucchinetti CF, Sorensen PS, Laursen H, Stadelmann C, Brück W, Rauschka H, Schmidbauer M, Lassmann H. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathology (Zurich, Switzerland). 17: 38-44. PMID 17493036 DOI: 10.1111/J.1750-3639.2006.00041.X |
0.45 |
|
| 2007 |
Lassmann H, Brück W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathology (Zurich, Switzerland). 17: 210-8. PMID 17388952 DOI: 10.1111/J.1750-3639.2007.00064.X |
0.521 |
|
| 2007 |
Pittock SJ, Lucchinetti CF. The pathology of MS: new insights and potential clinical applications. The Neurologist. 13: 45-56. PMID 17351524 DOI: 10.1097/01.Nrl.0000253065.31662.37 |
0.496 |
|
| 2007 |
Vana AC, Lucchinetti CF, Le TQ, Armstrong RC. Myelin transcription factor 1 (Myt1) expression in demyelinated lesions of rodent and human CNS Glia. 55: 687-697. PMID 17330875 DOI: 10.1002/Glia.20492 |
0.43 |
|
| 2007 |
Pirko I, Lucchinetti CF, Sriram S, Bakshi R. Gray matter involvement in multiple sclerosis. Neurology. 68: 634-42. PMID 17325269 DOI: 10.1212/01.Wnl.0000250267.85698.7A |
0.508 |
|
| 2007 |
Pittock SJ, Reindl M, Achenbach S, Berger T, Bruck W, Konig F, Morales Y, Lassmann H, Bryant S, Moore SB, Keegan BM, Lucchinetti CF. Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations. Multiple Sclerosis (Houndmills, Basingstoke, England). 13: 7-16. PMID 17294606 DOI: 10.1177/1352458506072189 |
0.47 |
|
| 2007 |
Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain : a Journal of Neurology. 130: 1194-205. PMID 17282996 DOI: 10.1093/Brain/Awl371 |
0.506 |
|
| 2006 |
Fox RJ, Kivisäkk P, Lee JC, Tucky B, Lucchinetti C, Rudick RA, Ransohoff RM. Chemokine receptors as biomarkers in multiple sclerosis. Disease Markers. 22: 227-33. PMID 17124344 |
0.318 |
|
| 2006 |
Weinshenker BG, Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA. NMO-IgG: a specific biomarker for neuromyelitis optica. Disease Markers. 22: 197-206. PMID 17124341 DOI: 10.1155/2006/586306 |
0.455 |
|
| 2006 |
Miller RC, Lachance DH, Lucchinetti CF, Keegan BM, Gavrilova RH, Brown PD, Weinshenker BG, Rodriguez M. Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience. International Journal of Radiation Oncology, Biology, Physics. 66: 1178-86. PMID 16965867 DOI: 10.1016/J.Ijrobp.2006.06.014 |
0.407 |
|
| 2006 |
Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Brück W, Lucchinetti C, Lassmann H. Remyelination is extensive in a subset of multiple sclerosis patients Brain. 129: 3165-3172. PMID 16921173 DOI: 10.1093/Brain/Awl217 |
0.466 |
|
| 2006 |
Pittock SJ, Lucchinetti CF. Inflammatory transverse myelitis: evolving concepts. Current Opinion in Neurology. 19: 362-8. PMID 16914974 DOI: 10.1097/01.Wco.0000236615.59215.D3 |
0.349 |
|
| 2006 |
Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Archives of Neurology. 63: 964-8. PMID 16831965 DOI: 10.1001/Archneur.63.7.964 |
0.348 |
|
| 2006 |
Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica Neurology. 66: 1485-1489. PMID 16717206 DOI: 10.1212/01.Wnl.0000216139.44259.74 |
0.475 |
|
| 2006 |
Pittock SJ, Weinshenker BG, Noseworthy JH, Lucchinetti CF, Keegan M, Wingerchuk DM, Carter J, Shuster E, Rodriguez M. Not every patient with multiple sclerosis should be treated at time of diagnosis. Archives of Neurology. 63: 611-4. PMID 16606780 DOI: 10.1001/Archneur.63.4.611 |
0.447 |
|
| 2006 |
Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Archives of Neurology. 63: 390-6. PMID 16533966 DOI: 10.1001/Archneur.63.3.390 |
0.379 |
|
| 2006 |
Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, Noseworthy J, Aksamit A, Carter J, Sirven J, Hunder G, Fatourechi V, Mokri B, Drubach D, Pittock S, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Archives of Neurology. 63: 197-202. PMID 16476807 DOI: 10.1001/Archneur.63.2.197 |
0.369 |
|
| 2006 |
Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Annals of Neurology. 59: 566-9. PMID 16453327 DOI: 10.1002/Ana.20770 |
0.303 |
|
| 2006 |
Schwartz KM, Erickson BJ, Lucchinetti C. Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology Neuroradiology. 48: 143-149. PMID 16447037 DOI: 10.1007/S00234-005-0024-5 |
0.398 |
|
| 2006 |
Morales Y, Parisi JE, Lucchinetti CF. The pathology of multiple sclerosis: evidence for heterogeneity. Advances in Neurology. 98: 27-45. PMID 16400825 |
0.317 |
|
| 2006 |
Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica American Journal of Ophthalmology. 142: 715-716. DOI: 10.1016/J.Ajo.2006.08.010 |
0.303 |
|
| 2005 |
Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain : a Journal of Neurology. 128: 2705-12. PMID 16230320 DOI: 10.1093/Brain/Awh641 |
0.449 |
|
| 2005 |
Kantarci OH, Morales Y, Ziemer PA, Hebrink DD, Mahad DJ, Atkinson EJ, Achenbach SJ, De Andrade M, Mack M, Ransohoff RM, Lassmann H, Bruck W, Weinshenker BG, Lucchinetti CF. CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis. Journal of Neuroimmunology. 169: 137-43. PMID 16182378 DOI: 10.1016/J.Jneuroim.2005.07.025 |
0.489 |
|
| 2005 |
Frohman EM, Filippi M, Stuve O, Waxman SG, Corboy J, Phillips JT, Lucchinetti C, Wilken J, Karandikar N, Hemmer B, Monson N, De Keyser J, Hartung H, Steinman L, Oksenberg JR, et al. Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions. Archives of Neurology. 62: 1345-56. PMID 16157741 DOI: 10.1001/Archneur.62.9.1345 |
0.467 |
|
| 2005 |
Keegan M, König F, McClelland R, Brück W, Morales Y, Bitsch A, Panitch H, Lassmann H, Weinshenker B, Rodriguez M, Parisi J, Lucchinetti CF. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet (London, England). 366: 579-82. PMID 16099294 DOI: 10.1016/S0140-6736(05)67102-4 |
0.401 |
|
| 2005 |
Pittock SJ, Lucchinetti CF, Parisi JE, Benarroch EE, Mokri B, Stephan CL, Kim KK, Kilimann MW, Lennon VA. Amphiphysin autoimmunity: paraneoplastic accompaniments. Annals of Neurology. 58: 96-107. PMID 15984030 DOI: 10.1002/Ana.20529 |
0.338 |
|
| 2005 |
Stadelmann C, Ludwin S, Tabira T, Guseo A, Lucchinetti CF, Leel-Ossy L, Ordinario AT, Brück W, Lassmann H. Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis. Brain : a Journal of Neurology. 128: 979-87. PMID 15774507 DOI: 10.1093/Brain/Awh457 |
0.423 |
|
| 2005 |
Lucchinetti CF. Update on the international project on pathologic correlates in MS. Multiple Sclerosis Journal. 11: 99-100. PMID 15732277 DOI: 10.1177/135245850501100120 |
0.345 |
|
| 2005 |
Lucchinetti CF, Parisi J, Bruck W. The pathology of multiple sclerosis. Neurologic Clinics. 23: 77-105, vi. PMID 15661089 DOI: 10.1016/J.Ncl.2004.09.002 |
0.514 |
|
| 2004 |
Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet (London, England). 364: 2106-12. PMID 15589308 DOI: 10.1016/S0140-6736(04)17551-X |
0.468 |
|
| 2004 |
Lucchinetti CF, Bruck W, Lassmann H, Barnett MH, Prineas JW. Evidence for pathogenic heterogeneity in multiple sclerosis [2] (multiple letters) Annals of Neurology. 56: 308-309. PMID 15293289 DOI: 10.1002/Ana.20182 |
0.424 |
|
| 2004 |
Lucchinetti C, Bruck W. The pathology of primary progressive multiple sclerosis. Multiple Sclerosis Journal. 8: 93-97. PMID 15218806 DOI: 10.1191/1352458504Ms1027Oa |
0.53 |
|
| 2004 |
Mahad DJ, Trebst C, Kivisäkk P, Staugaitis SM, Tucky B, Wei T, Lucchinetti CF, Lassmann H, Ransohoff RM. Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions. Journal of Neuropathology and Experimental Neurology. 63: 262-73. PMID 15055450 DOI: 10.1093/Jnen/63.3.262 |
0.413 |
|
| 2004 |
Höftberger R, Aboul-Enein F, Brueck W, Lucchinetti C, Rodriguez M, Schmidbauer M, Jellinger K, Lassmann H. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathology (Zurich, Switzerland). 14: 43-50. PMID 14997936 DOI: 10.1111/J.1750-3639.2004.Tb00496.X |
0.418 |
|
| 2004 |
Pittock SJ, Weinshenker BG, Lucchinetti CF. Bright red nuclei. Neurology. 62: 619. PMID 14981180 DOI: 10.1212/01.Wnl.0000116137.67886.F8 |
0.317 |
|
| 2003 |
Pittock SJ, Lucchinetti CF, Lennon VA. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Annals of Neurology. 53: 580-7. PMID 12730991 DOI: 10.1002/Ana.10518 |
0.36 |
|
| 2003 |
Trebst C, Staugaitis SM, Kivisäkk P, Mahad D, Cathcart MK, Tucky B, Wei T, Rani MR, Horuk R, Aldape KD, Pardo CA, Lucchinetti CF, Lassmann H, Ransohoff RM. CC chemokine receptor 8 in the central nervous system is associated with phagocytic macrophages. The American Journal of Pathology. 162: 427-38. PMID 12547701 DOI: 10.1016/S0002-9440(10)63837-0 |
0.439 |
|
| 2003 |
Aboul-Enein F, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Brück W, Lucchinetti C, Schmidbauer M, Jellinger K, Lassmann H. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases Journal of Neuropathology and Experimental Neurology. 62: 25-33. PMID 12528815 DOI: 10.1093/Jnen/62.1.25 |
0.495 |
|
| 2002 |
Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain : a Journal of Neurology. 125: 1450-61. PMID 12076996 DOI: 10.1093/Brain/Awf151 |
0.459 |
|
| 2001 |
Bitsch A, Kuhlmann T, Stadelmann C, Lassmann H, Lucchinetti CF, Brück W. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Annals of Neurology. 49: 793-796. PMID 11409432 DOI: 10.1002/Ana.1053 |
0.448 |
|
| 2001 |
Lucchinetti CF, Brück W, Noseworthy J. Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment. Current Opinion in Neurology. 14: 259-269. PMID 11371747 DOI: 10.1097/00019052-200106000-00002 |
0.459 |
|
| 2001 |
Wingerchuk DM, Lucchinetti CF, Noseworthy JH. Multiple sclerosis: current pathophysiological concepts Laboratory Investigation. 81: 263-281. PMID 11310820 DOI: 10.1038/Labinvest.3780235 |
0.468 |
|
| 2001 |
Lassmann H, Brück W, Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends in Molecular Medicine. 7: 115-121. PMID 11286782 DOI: 10.1016/S1471-4914(00)01909-2 |
0.435 |
|
| 2000 |
Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Annals of Neurology. 47: 707-17. PMID 10852536 DOI: 10.1002/1531-8249(200006)47:6<707::Aid-Ana3>3.0.Co;2-Q |
0.542 |
|
| 2000 |
Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain : a Journal of Neurology. 2279-95. PMID 10581222 DOI: 10.1093/Brain/122.12.2279 |
0.457 |
|
| 1999 |
Weinshenker BG, O'Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, Pineda AA, Stevens LN, Rodriguez M. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Annals of Neurology. 46: 878-86. PMID 10589540 DOI: 10.1002/1531-8249(199912)46:6<878::Aid-Ana10>3.0.Co;2-Q |
0.386 |
|
| 1999 |
Rodriguez M, Lucchinetti CF. Is apoptotic death of the oligodendrocyte a critical event in the pathogenesis of multiple sclerosis? Neurology. 53: 1615-6. PMID 10563600 DOI: 10.1212/Wnl.53.8.1615 |
0.444 |
|
| 1999 |
Kuhlmann T, Lucchinetti C, Zettl UK, Bitsch A, Lassmann H, Brück W. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions. Glia. 28: 34-39. PMID 10498820 DOI: 10.1002/(Sici)1098-1136(199910)28:1<34::Aid-Glia4>3.0.Co;2-8 |
0.514 |
|
| 1999 |
Sørensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM, Frederiksen JL, Ransohoff RM. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients Journal of Clinical Investigation. 103: 807-815. PMID 10079101 DOI: 10.1172/Jci5150 |
0.453 |
|
| 1998 |
Lucchinetti CF, Brueck W, Rodriguez M, Lassmann H. Multiple sclerosis: lessons from neuropathology. Seminars in Neurology. 18: 337-349. PMID 9817538 DOI: 10.1055/S-2008-1040885 |
0.525 |
|
| 1998 |
Lucchinetti CF, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. PATTERNS OF MULTIPLE SCLEROSIS IMMUNOPATHOLOGY Journal of Neuropathology and Experimental Neurology. 57: 489. DOI: 10.1097/00005072-199805000-00089 |
0.396 |
|
| 1998 |
Ransohoff RM, Tani M, Pierce V, Lucchinetti C, Sorensen T, Streiter RM. Chemokine receptors in multiple sclerosis Journal of Neuroimmunology. 90: 9. DOI: 10.1016/S0165-5728(98)91248-6 |
0.345 |
|
| 1997 |
Lucchinetti CF, Kiers L, O'Duffy A, Gomez MR, Cross S, Leavitt JA, O'Brien P, Rodriguez M. Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology. 49: 1413-8. PMID 9371931 DOI: 10.1212/Wnl.49.5.1413 |
0.404 |
|
| 1997 |
Lucchinetti CF, Kimmel DW, Pavelko K, Rodriguez M. 5-Fluorouracil and levamisole exacerbate demyelination in susceptible mice infected with Theiler's virus. Experimental Neurology. 147: 123-9. PMID 9294409 DOI: 10.1006/Exnr.1997.6598 |
0.303 |
|
| 1997 |
Lassmann H, Brück W, Lucchinetti C, Rodriguez M. Remyelination in multiple sclerosis. Multiple Sclerosis Journal. 3: 133-136. PMID 9291167 DOI: 10.1177/135245859700300213 |
0.51 |
|
| 1997 |
Lucchinetti CF, Noseworthy JH, Rodriguez M. Promotion of endogenous remyelination in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 3: 71-5. PMID 9291156 DOI: 10.1177/135245859700300202 |
0.449 |
|
| 1997 |
Lucchinetti CF, Brück W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathology (Zurich, Switzerland). 6: 259-74. PMID 8864283 DOI: 10.1111/J.1750-3639.1996.Tb00854.X |
0.474 |
|
| 1997 |
Lucchinetti CF, Rodriguez M. The Controversy Surrounding the Pathogenesis of the Multiple Sclerosis Lesion Mayo Clinic Proceedings. 72: 665-678. DOI: 10.4065/72.7.665 |
0.475 |
|
| Show low-probability matches. |